182 results on '"Voss, F."'
Search Results
2. Human Myocardial Mitochondrial Function is Impaired in Cardiac Light Chain Amyloidosis but Not in Transthyretin Amyloidosis
3. Effect of Cytomegalovirus Prophylaxis with Immunoglobulins or Antiviral Drugs on Lymphoproliferative Disease After Heart Transplantation: Single-Center Experience in 300 Patients
4. Heart Transplantation in Patients on Temporary Mechanical Circulatory Support
5. Anthracycline therapy induces an early decline of cardiac contractility with transient edema in low risk patients with breast cancer
6. Validating available Donor-recipient risk assessment tools in a German Heart Transplant cohort
7. Impact of fast tacrolimus metabolizer status on outcome after heart transplantation
8. German Cardiac Arrest Registry (G-CAR): results of the pilot phase
9. Measurement and analysis of the Am-243 neutron capture cross section at the n_TOF facility at CERN
10. De Novo Malignancies after Heart Transplantation—A Single Center Experience.
11. POS1329 DESIGN OF A PHASE III, RANDOMISED, PLACEBO-CONTROLLED TRIAL OF BI 1015550 IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE
12. Gender-specific differences in young patients receiving implantable cardioverter-defibrillator therapy - a subgroup analysis of the german device registry
13. Effects of baseline symptom burden on treatment response in COPD
14. (656) Assessment of Risk Factors for Cytomegalovirus DNAemia after Termination of Regular Prophylaxes after Heart Transplantation
15. Impact of SARS-CoV-2 Infection on Reactivation of Herpesviridae after Heart and Heart and Kidney Transplantation
16. Subclinical Myocardial Leukocyte Infiltration after Covid-19-Vaccination in Heart-Transplant Recipients
17. Safety and Efficacy of BI 1015550, a Preferential Inhibitor of Phosphodiesterase 4B, in Patients with Idiopathic Pulmonary Fibrosis: a Phase 2 Trial*
18. Sécurité d’emploi et efficacité de Bl 1015550, un inhibiteur préférentiel de la phosphodiestérase 4B (PDE4Bi), chez des patients atteints de fibrose pulmonaire idiopathique : essai de phase II
19. Subclinical Myocardial Leukocyte Infiltration after COVID-19 Vaccination in Heart-Transplant Recipients
20. Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO® and OTEMTO® studies: a subgroup analysis by age
21. The efficacy and safety of combined tiotropium and olodaterol via the Respimat® inhaler in patients with COPD: results from the Japanese sub-population of the Tonado® studies
22. 10-year follow-up of interventional electrophysiology: updated German survey during the COVID-19 pandemic.
23. Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis
24. Procedure related complications following implantation of cardiac resynchronization therapy (CRT) and implantable cardioverter-defibrillator (ICD) devices - Insights from the German DEVICE registry
25. Decline in forced vital capacity as a surrogate for mortality in patients with fibrosing interstitial lung diseases*
26. Safety and Efficacy of BI 1015550, a Preferential Inhibitor of Phosphodiesterase 4b, in Patients with Idiopathic Pulmonary Fibrosis: A Phase 2 Trial
27. (510) - Effect of Cytomegalovirus Prophylaxis with Immunoglobulins or Antiviral Drugs on Lymphoproliferative Disease After Heart Transplantation: Single-Center Experience in 300 Patients
28. Diagnostik bei supraventrikulären Tachykardien: Wie ist das Vorgehen im elektrophysiologischen Labor?
29. Minimally Invasive Surgical Ablation Combined with Postoperative Electrophysiological Evaluation and Intervention Is Highly Effective in the Treatment of Intermittent and Long-Standing Atrial Fibrillation
30. Decline in Forced Vital Capacity as a Surrogate for Mortality in Patients with Fibrosing Interstitial Lung Diseases
31. Dissemination of data measured at the CERN n_TOF facility
32. Optimal antithrombotic regimen in patients with cardiogenic shock on ImpellaTM mechanical support: less might be more
33. High accuracy 235U(n,f) data in the resonance energy region
34. Towards the high-accuracy determination of the 238U fission cross section at the threshold region at CERN – n_TOF
35. Postcard to J.M. Synge from ?F. Voss, 16 Nov 1908
36. Lipidation of Pneumococcal Antigens Leads to Improved Immunogenicity and Protection
37. (650) Impact of SARS-CoV-2 Infection on Reactivation of Herpesviridae after Heart and Heart and Kidney Transplantation
38. (417) Subclinical Myocardial Leukocyte Infiltration after Covid-19-Vaccination in Heart-Transplant Recipients
39. (374) - Human Myocardial Mitochondrial Function is Impaired in Cardiac Light Chain Amyloidosis but Not in Transthyretin Amyloidosis.
40. Früh postoperative pulmonalvenöse Stauung nach Herztransplantation: Wird das Outcome beeinflusst?
41. Study Design of a Phase III, Randomized, Placebo-Controlled Trial of Nintedanib in Children and Adolescents with Clinically Significant Fibrosing Interstitial Lung Disease (ILD)
42. Benefits of tiotropium/olodaterol compared with tiotropium in patients receiving COPD LAMA at baseline: pooled analysis of 4 clinical trials
43. Efficacy of tiotropium/olodaterol compared with tiotropium in patients naive to LAMA, LABA and ICS: Pooled analysis of four clinical trials
44. Up-skilling Human Capital for Value-chain Competitiveness in Uruguay
45. Mejorar las habilidades del capital humano para la competitividad de las cadenas de valor en el Uruguay
46. S102 Eosinophil counts as a predictor of future COPD exacerbations in the DYNAGITO trial
47. S29 The impact of GOLD stage on the effectiveness of tiotropium/olodaterol in preventing COPD exacerbations in the DYNAGITO trial
48. Efficacy of Tiotropium/Olodaterol Compared with Tiotropium in Patients Naïve to LAMA, LABA and ICS: Pooled Analysis of Four Clinical Trials
49. The Frequency of Exacerbations Treated with Antibiotics, Steroids or Both Differs by GOLD Stage in Patients with COPD in the DYNAGITO Trial
50. Treatment of First Exacerbation Predicts Future Risk of Exacerbations in Patients with COPD in the DYNAGITO Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.